Stamford, CT -- (SBWIRE) -- 02/06/2013 -- Jet Life Penny Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletters and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Opexa Therapeutics Inc.(NASDAQ:OPXA) reported the gain of +160.33% and closed at $3.15 with the total traded volume of 9.82 million shares. The company has recently entered into an agreement with Merck Serono, which Ascendiant Capital Markets LLC senior health care research analyst Keay Nakae believes a good step forward. Its opening price was $4.71 and its shares were trading within the range of $3.05-$5.19.
OPXAhas earnings per share of -$1.52 with the market cap of $22.71million.
What was the Moving Force behind OPXAOn Bullish Run? Read This Research Report
Celsion Corporation(NASDAQ:CLSN) gained +5.13% with the closing price of $1.23. The overall volume in the last trading session was 8.43 million shares. Its fifty two week range was $1.13-$9.44. The total market capitalization remained $43.07million.
CLSN is ahead its 52 week low with 8.85% and its last month price volatility remained 10.86%. Its beta coefficient was 1.32 with a target price of $20.73. In its share capital CLSN has 35.01 million outstanding shares while 34.06 million shares have been floated in market. CLSN has insider ownership of 2.56% with its institutional ownership remained 15.92%. Company’s current year earnings per share grew with 26.99%.
Will CLSN Continue To Move Higher? Find Out Here
ProtalixBioTherapeutics Inc.(NYSEAMEX:PLX) surged +14.74% and closed at $6.15 in the last trading session with the overall traded volume of 7.49 million shares more than the average volume of 212,072 shares. Stock price 52 weeks high was $7.70 and its 52 weeks low price was $4.71.
PLXhas current ratio of 2.92. It has market cap of $574.84million while its total outstanding shares are 93.47million.
For How Long PLX will Fight for Profitability? Read This Trend Analysis report
HemispherxBioPharma, Inc(NYSEAMEX:HEB) declined -14.69% with the closing price of $0.222 after failure to win US Approval for Chronic Fatigue. The overall volume in the last trading session was 6.24 million shares. Its fifty two week range was $0.18-$1.10. The total market capitalization remained $33.49 billion.
HEB is ahead its 52 week low with 28.03% and its last month price volatility remained 11.51%. Its beta coefficient was 1.28. In its share capital HEB has 151.01million outstanding shares while 132.39million shares have been floated in market. HEB has insider ownership of 0.98% with its institutional ownership remained 4.85%. Company’s current year earnings per share grew with 32.10%.
Will HEB Get Buyers Even After The Recent Rally? Find Out Here
VIVUS, Inc.(NASDAQ:VVUS) reported the gain of +6.58% to close at $12.96 in the last trading session after the release of new data for prescriptions of its weight-loss pill, Qsymia. Its total traded volume was 5.82 million shares beating the average volume of 4.80 million. VVUS has market cap of $1.30 billion.
VVUS has earnings per share of -$0.98. VVUS has negative year-to-date performance of -3.43% and is trading above its 50 day moving average of +2.35% and 200 day moving average of -34.25%.
For How Long VVUS’s Gloss will Attract Investors? Find out via this report
Inovio Pharmaceuticals, Inc.(NYSEAMEX:INO) jumped +11.11% and closed at $0.800 with the overall traded volume of 5.47 million shares. Stock price 52 weeks high was $0.81 and 52 weeks low price was $0.38. INOhas market cap of $111.49million and its beta value stands at 2.77 times. INOhas earnings per share of -$0.18 and its price to sales ratio ended at 24.13 times.
Where INO is Headed Exactly? Find out in This Trend Analysis Reports
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)